Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares, on December 12, 2017. The filing serves to distribute a press release issued on the same date to U.S. investors. The registrant files annual reports under Form 20-F.
Financial Metrics
The provided filing text contains only the cover page, signature block, and exhibit reference for a press release. It does not include the content of the press release itself. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.
Material Changes
As the specific financial data and operational updates are contained within the referenced press release (Exhibit 99.1) rather than the cover document, no material changes versus the prior comparable period can be identified from this text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements would be located in the attached press release, which is not included in the input content.
Key Facts for Investor Verification
- The filing is a procedural Form 6-K referencing an external press release dated December 12, 2017.
- Financial performance data is not present in the cover document; investors must review Exhibit 99.1 for actual figures.
- The document is signed by Rice Powell (CEO) and Michael Brosnan (CFO).
- The registrant is a Foreign Private Issuer reporting under Rule 13a-16.